Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection

非洲人群的免疫球蛋白基因多样性及其对 HIV 感染中抗体功能的影响

基本信息

  • 批准号:
    10226240
  • 负责人:
  • 金额:
    $ 24.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-18 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Antibodies are critical components of immune defense and are mediators of vaccine-elicited protection as well as autoimmunity. The heavy and light chains that comprise an antibody molecule are encoded by germline immunoglobulin (Ig) gene fragments that recombine and undergo somatic mutation thereby generating billions of specificities able to contend with a multitude of foreign antigens. The majority of the diversity lies within the antigen-binding (Fab) portion of antibodies although variation also exists within the conserved (Fc) region of the heavy chain that interacts with cellular receptors to mediate non-neutralizing functions. Diversity within both regions impacts on antibody function. Given the protective role of antibodies in HIV and other infections, we propose to mine the depth of the antibody repertoire and study how Fc diversity impacts antiviral activity. It is well known that Africans are more genetically diverse than other populations and yet there is a scarcity of data on African genomes including Ig genes. Our preliminary data using samples from an ethnic Zulu population residing in South Africa has revealed that approximately half of the heavy chain variable (IGHV) genes as well as a significant number of single nucleotide polymorphisms (SNPs) in the Fc are not recorded in public databases. Many of these novel IGHV alleles occur at high frequency and in some cases are highly expressed. Importantly, we have shown that they are used to make functional antibodies. We hypothesize that there is significant undiscovered variability within the African Ig gene repertoire some of which will impact on the functionality of anti-HIV antibodies. To explore this, we propose to sequence the entire rearranged, antigen-naïve heavy and light variable chain gene repertoires in 40 individuals of Zulu ethnicity using Illumina MiSeq. Data will be analyzed using a new bioinformatics tool called IgDiscover that will enable the identification of novel and known germline variable and joining region gene segments from both heavy and light chains that are expressed by functional antibodies. Variability in the Fc region of IgG and IgA will be analyzed using SNP analysis in 100 Zulu individuals. Furthermore, the Fc regions from individuals with novel IgG3 SNPs will be sequenced and used to make fully native antibodies for functional studies, including antibody-dependent cellular cytotoxicity (ADCC), phagocytosis and neutralization. In this way the diversity within both the Fab and Fc regions will be analyzed and the impact on function assessed. This project will contribute new knowledge on African germline immunoglobulin genes, which is essential for a fully comprehensive immunogenetics database. These studies will be of great benefit to the HIV research community as they embark on major vaccine efficacy trials as well as to others studying the immune responses to infection, vaccination, cancer and auto-immunity in this population.
项目总结 抗体是免疫防御的重要组成部分,也是疫苗诱导保护的媒介。 作为自身免疫力。构成抗体分子的重链和轻链由生殖系编码。 免疫球蛋白(Ig)基因片段重组并经历体细胞突变,从而产生数十亿 能够对抗多种外来抗原的特异性。大部分的多样性存在于 抗体的抗原结合(Fab)部分,尽管在保守的(Fc)区也存在变异 与细胞受体相互作用以调节非中和功能的重链。两者之间的多样性 地区对抗体功能的影响。考虑到抗体在艾滋病毒和其他感染中的保护作用,我们 建议挖掘抗体库的深度,并研究Fc多样性如何影响抗病毒 活动。 众所周知,非洲人的基因比其他人更多样化,但却缺乏 关于包括免疫球蛋白基因在内的非洲基因组的数据。我们使用祖鲁族样本的初步数据 居住在南非的人口显示,大约一半的重链可变(IGHV) Fc中的基因以及大量单核苷酸多态(SNPs)没有记录在 公共数据库。这些新的IGHV等位基因中有许多是高频出现的,在某些情况下还很高 表达。重要的是,我们已经证明它们被用来制造功能性抗体。我们假设 在非洲免疫球蛋白基因谱系中存在着重大的未被发现的变异,其中一些将 对抗HIV抗体功能的影响。 为了探索这一点,我们建议对整个重排的、抗原天真的重链和轻链进行测序 应用Illumina MiSeq对40名祖鲁族人的基因库进行分析数据将使用新的 名为IgDiscover的生物信息学工具,它将能够识别新的和已知的生殖系变量和 连接由功能性抗体表达的重链和轻链的区域基因片段。 将对100名祖鲁族人进行SNP分析,以分析Ig G和Ig A Fc区的变异性。 此外,来自具有新的IgG3 SNPs的个体的Fc区域将被测序并用于完全 用于功能研究的天然抗体,包括抗体依赖的细胞毒性(ADCC), 吞噬和中和作用。通过这种方式,将分析FAB和FC区域内的多样性 以及对功能的影响评估。 该项目将提供有关非洲生殖系免疫球蛋白基因的新知识,这对 全面的免疫遗传学数据库。这些研究将对艾滋病的研究大有裨益。 社区正在进行主要的疫苗效力试验,以及其他研究免疫反应的人 感染、疫苗接种、癌症和自身免疫。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Antibody class-switching as a strategy to improve HIV-1 neutralization.
  • DOI:
    10.1016/j.molmed.2022.08.010
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Scheepers, Cathrine;Richardson, Simone I.;Moyo-Gwete, Thandeka;Moore, Penny L.
  • 通讯作者:
    Moore, Penny L.
The antibody response in HIV-1-infected donors.
HIV-1 感染捐赠者的抗体反应。
  • DOI:
    10.1097/coh.0000000000000559
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Richardson,SimoneI;Moore,PennyL
  • 通讯作者:
    Moore,PennyL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lynn Morris其他文献

Lynn Morris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lynn Morris', 18)}}的其他基金

Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection
非洲人群的免疫球蛋白基因多样性及其对 HIV 感染中抗体功能的影响
  • 批准号:
    9754773
  • 财政年份:
    2017
  • 资助金额:
    $ 24.64万
  • 项目类别:
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec
HIV感染者中聚糖反应性广泛中和抗v2抗体的进化
  • 批准号:
    8542060
  • 财政年份:
    2013
  • 资助金额:
    $ 24.64万
  • 项目类别:
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec
HIV感染者中聚糖反应性广泛中和抗v2抗体的进化
  • 批准号:
    8707964
  • 财政年份:
    2013
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    8228238
  • 财政年份:
    2011
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    7904631
  • 财政年份:
    2010
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    8710704
  • 财政年份:
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    8429450
  • 财政年份:
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    8376698
  • 财政年份:
  • 资助金额:
    $ 24.64万
  • 项目类别:
Characterizing HIV-1 Envs associated with potent bnAbs agains QNEs
表征与针对 QNE 的有效 bnAb 相关的 HIV-1 Envs
  • 批准号:
    8720669
  • 财政年份:
  • 资助金额:
    $ 24.64万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 24.64万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 24.64万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 24.64万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 24.64万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 24.64万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了